Federated Hermes’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02K Buy
+320
New +$3.06K ﹤0.01% 1966
2025
Q3
Sell
-331
Closed -$2.19K 2131
2025
Q2
$2.19K Buy
+331
New +$2.35K ﹤0.01% 1954
2025
Q1
Sell
-294
Closed -$3.09K 2072
2024
Q4
$3.09K Sell
294
-695
-70% -$8.22K ﹤0.01% 1938
2024
Q3
$11.8K Sell
989
-190
-16% -$1.64K ﹤0.01% 1795
2024
Q2
$6.78K Sell
1,179
-660
-36% -$3.62K ﹤0.01% 1813
2024
Q1
$9.56K Hold
1,839
﹤0.01% 1781
2023
Q4
$9.69K Buy
1,839
+1,497
+438% +$5.92K ﹤0.01% 1795
2023
Q3
$1.13K Sell
342
-1,223
-78% -$4.29K ﹤0.01% 2004
2023
Q2
$4.52K Sell
1,565
-2,616
-63% -$5.02K ﹤0.01% 1909
2023
Q1
$4.47K Buy
4,181
+2,152
+106% +$4.12K ﹤0.01% 1945
2022
Q4
$5.3K Buy
+2,029
New +$8.86K ﹤0.01% 1922
2022
Q2
Sell
-2,194
Closed -$31K 2158
2022
Q1
$31K Hold
2,194
﹤0.01% 1786
2021
Q4
$32K Hold
2,194
﹤0.01% 1833
2021
Q3
$31K Buy
+2,194
New +$33.8K ﹤0.01% 1907

Other funds holding BVS

Federated Hermes's BVS Position: Q2 2026 in Review

Federated Hermes opened a new position in Bioventus (BVS) in Q2 2026: 320 shares worth $3.02K. The stake represents ﹤0.01% of the portfolio and ranks #1966 among its holdings. This is a return to the name: Federated Hermes previously reported a position in BVS as recently as Q2 2025.

Federated Hermes first reported a position in BVS in Q3 2021 and has held it in 14 quarters since. The position peaked at $32K in Q4 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Federated Hermes held 320 shares of Bioventus worth $3.02K as of Q2 2026.
  • Bioventus was a new Federated Hermes position in Q2 2026.
  • Bioventus made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1966 holding.
  • Federated Hermes first reported a position in Bioventus in Q3 2021 and has held it in 14 quarters since.
  • Federated Hermes's Bioventus position peaked at $32K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.